Does Stopping Aspirin Differ Fundamentally From Not Starting Aspirin in the Primary Prevention of Cardiovascular Disease Among Older Adults?

Ann Intern Med. 2022 May;175(5):757-758. doi: 10.7326/M22-0550. Epub 2022 Mar 15.

Authors

Ella Murphy¹, John W McEvoy²

Affiliations

¹ University Hospital Galway, Saolta University Health Care Group, and National University of Ireland Galway, Galway, Ireland.
² University Hospital Galway, Saolta University Health Care Group, National University of Ireland Galway, and National Institute for Prevention and Cardiovascular Health, National University of Ireland Galway, Galway, Ireland.

PMID: 35286142
DOI: 10.7326/M22-0550

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aged
Aspirin* / adverse effects
Cardiovascular Diseases* / prevention & control
Humans
Platelet Aggregation Inhibitors / therapeutic use
Primary Prevention

Substances

Platelet Aggregation Inhibitors
Aspirin